Related by context. All words. (Click for frequent words.) 68 IMA# 67 CR# vcMMAE 67 Phase #b/#a clinical 67 GRNVAC1 66 DPX Survivac 66 NP2 Enkephalin 66 mertansine 66 PEG SN# 66 trastuzumab DM1 T DM1 66 CBLC# 66 Bezielle 66 OvaRex ® MAb 66 Thiovir 66 Surfaxin LS 65 Tectin TM 65 Listeria vaccine 65 Phase Ib study 65 GLP toxicology studies 65 huC# DM4 65 oral prodrug 65 oncolytic virus therapies 65 BrachySil 64 TACI Ig 64 tramiprosate Alzhemed TM 64 alvespimycin 64 Alocrest 64 Immunotherapeutic 64 YONDELIS 64 FluINsure 64 VitiGam 64 GVAX ® 64 Phase III Pivotal 64 immunotherapeutic vaccine 64 rPA anthrax vaccine 64 orally dosed 64 radiolabeled TM# 64 Phase IIb clinical trials 64 oral ridaforolimus 64 Archexin 64 PrevOnco 64 liprotamase 64 ganetespib 64 recurrent metastatic 64 CRLX# 64 immuno therapeutic 64 Hepatocellular Carcinoma HCC 63 GALNS 63 cannabinor 63 ADXS# 63 phase IIa clinical 63 phase IIb III 63 Proellex TM 63 Chimigen TM 63 IMC #B 63 Telatinib 63 CEQ# 63 Aryplase 63 Aurexis 63 MAGE A3 ASCI 63 Fodosine 63 OncoVEX 63 investigational hepatitis B 63 RhuDex 63 phase IIb clinical 63 OncoVEX GM CSF 63 Phase 1b clinical trials 63 TELINTRA 63 PNT# 63 Radezolid 63 phase IIa 63 Phase #b/#a 63 Quinamed 63 THR beta agonist 63 Phase Ib II 63 JAK inhibitor 63 Protexia R 63 reslizumab 63 BrachySil TM 63 ChronVac C R 63 TBC# 63 lucinactant 63 #I TM# 63 HuMax EGFr 63 RIGScan CR 63 RhuDex ® 62 Aerosurf 62 pharmacokinetic PK study 62 lomitapide 62 telomerase therapeutic 62 velafermin 62 KNS # 62 UPLYSO 62 Cloretazine 62 budesonide foam 62 Allovectin 7 62 Chemophase 62 EchoCRT 62 Aflibercept 62 LymphoStat B TM 62 hormone LHRH antagonist 62 OMP #M# 62 Azedra 62 phase Ib clinical 62 XmAb# 62 TNFerade TM 62 Reolysin 62 preclinical efficacy 62 PrevOnco ™ 62 Dalbavancin 62 drug GAP #B# 62 Twinrix 62 SinuNase TM 62 ONCONASE R 62 Vandetanib 62 Multimeric 62 docetaxel Taxotere R 62 Annamycin 62 Altastaph 62 PSMA ADC 62 Combination REOLYSIN R 62 radezolid 62 forodesine 62 HuMax CD4 62 RiVax 62 Liprotamase 62 TLK# 62 REOLYSIN ® 62 Advaxis Phase 62 PROSTVAC TM 62 antibody MAb 62 immatics 62 Temsirolimus 62 OvaRex R 62 Vaxfectin 62 apricitabine ATC 62 rALLy clinical trial 62 initiated Phase 1b 62 ADVANCE PD 62 PREVENAR 62 tiapamil 62 BioVant 62 IIa trial 62 tanespimycin 61 Phase Ib clinical trials 61 Curaxin CBLC# 61 Alferon N 61 CMV vaccine 61 Ozarelix 61 BRIM2 61 Phase 2a clinical trials 61 Anthim 61 Capesaris 61 PRT# 61 MAXY alpha 61 Bayer HealthCare Onyx Pharmaceuticals 61 Phase Ib clinical 61 MKC# MKC# PP 61 ATL# [001] 61 CERVARIX 61 stable nucleic acid 61 liposomal formulation 61 LEAPS TM 61 Phase #b/#a trial 61 Phase IIb III 61 phase IIb study 61 Aplidin 61 DORIBAX 61 MGN# 61 Eniluracil 61 MyVax ® 61 ROTARIX 61 human IgG1 monoclonal 61 TOCOSOL Camptothecin 61 Phase IIIb clinical 61 torezolid phosphate 61 Phase III confirmatory 61 Adjuvanted 61 rindopepimut 61 ImmunoVEX HSV2 61 NeuVax 61 GW# [003] 61 inhaled AAT 61 IL# PE#QQR 61 Personalized Immunotherapy 61 ALN TTR# 61 LHRH antagonist 61 hepatitis C viral infection 61 CRD5 61 GVAX R 61 IoGen 61 Lenocta TM 61 Proxinium TM 61 ulimorelin 61 tolevamer 61 Cand5 61 acyclovir Lauriad R 61 personalized dendritic cell 61 HQK 61 PRTX 61 XmAb 61 Tesetaxel 61 HspE7 61 Fibrillex TM 61 ELACYT 61 Panzem R NCD 61 DermaVir Patch 61 BAY #-# 61 CTAP# Capsules 61 histone deacetylase inhibitor 61 Zalypsis 61 midstage trials 61 Certolizumab pegol 61 Exherin TM 61 CoFactor 61 Prodarsan 61 ClearPath HDR 61 GRN# 61 Cloretazine ® 61 pertuzumab 61 non nucleoside inhibitor 61 BLA filing 61 Onalta 61 SparVax TM 61 vosaroxin 61 Vicinium TM 61 Sapacitabine 61 oral picoplatin 61 VivaGel TM 61 Veronate 61 riociguat 61 Xanafide 61 investigational monoclonal antibody 61 preclinically 61 Phase Ib 61 systemic RNAi therapeutic 60 confirmatory Phase III 60 Vaxfectin TM 60 Poly ICLC 60 phase Ib 60 Angiocept 60 ketolide antibiotic 60 anticancer compound 60 ImQuest 60 novel therapeutic antibodies 60 Velcade bortezomib 60 AEG# 60 Elagolix 60 Anturol TM 60 #D#C# 60 Vitaxin 60 OvaRex 60 Phase IIB 60 MenACWY 60 Afatinib 60 INCB# [001] 60 FOLOTYN ® 60 fosbretabulin 60 Factor VIIa 60 vinorelbine tartrate 60 Onconase 60 Allovectin 7 ® 60 Golimumab 60 volociximab 60 RAV# 60 dimebon latrepirdine 60 Guanilib 60 Ceflatonin 60 DAVANAT 60 aerosolized KL4 surfactant 60 Myocet 60 Oracea TM 60 Tesmilifene 60 Motavizumab 60 Alinia 60 CA9 SCAN 60 StemEx R 60 Hedgehog antagonist 60 Fx #A 60 MVA BN 60 DepoVax TM 60 CD# CEA 60 GSK# [001] 60 Bicifadine 60 Phase IIb trials 60 neratinib 60 Phase III multicenter 60 Allovectin 7 R 60 Japanese Encephalitis vaccine 60 Phase #/#a trial 60 MEK inhibitor RDEA# 60 FluCide 60 monoclonal antibody conjugated 60 Vaxfectin ® 60 cetrorelix pamoate 60 AKT inhibitor 60 BEZ# 60 Traficet EN 60 SPL# Gel vaginal microbicide 60 pseudobulbar affect PBA 60 HGS ETR1 60 ChronVac C ® 60 CURE AF 60 RhuDex TM 60 OncoVex 60 ZK EPO 60 IRX 2 60 OHR/AVR# 60 Stimuvax R 60 Genasense ® oblimersen 60 vidofludimus 60 AFFiRiS GmbH 60 Imvamune 60 Symadex 60 JZP 60 LEP ETU 60 GTC recombinant human 60 Prostate AdenoCarcinoma Treatment 60 BLP# Liposome Vaccine 60 PROCHYMAL 60 BHT DNA 60 Phase IIb Trial 60 DepoVax ™ 60 PANVAC VF 60 GeoVax HIV AIDS 60 EP #R 60 enzastaurin 60 YONDELIS R 60 catheter occlusion 60 Aurora kinase inhibitor 60 CCX# 60 Alzhemed TM 60 SUCCEED trial 60 Carfilzomib 60 targeted radiotherapeutic 60 bevirimat Study 60 CCR5 mAb 60 HDAC Inhibitor 60 Ridaforolimus 60 vaccine LAIV 60 HDL Selective Delipidation 60 Aplidin R 60 CYT# potent vascular disrupting 60 Neuvenge 60 Protectan 60 Tarceva TM 60 virus HCV protease inhibitor 60 Phenoptin 60 dose intramuscular 60 Pivotal Phase III 60 Cetrorelix 60 Celator 60 Cethromycin 60 pradefovir 60 Nexavar sorafenib 60 Insegia 60 StemEx 60 talactoferrin 59 MelaFind R 59 DCVax ® 59 BioNumerik 59 GOUT 59 cancer immunotherapies 59 Zoraxel 59 Dacogen injection 59 TELCYTA 59 Urocidin 59 Hedgehog Pathway Inhibitor 59 ANTEGREN 59 PDE4 inhibitor 59 Evoltra ® 59 subcutaneous formulation 59 Pafuramidine 59 Phase 2b Clinical Trial 59 ALN VSP 59 Daclizumab 59 Vion Pharmaceuticals 59 investigational humanized monoclonal antibody 59 please visit www.advaxis.com 59 IND submission 59 StaphVAX R 59 ALN PCS 59 tremelimumab 59 unique alkylating agent 59 Elotuzumab 59 HCV protease inhibitor 59 ChimeriVax JE 59 multicenter Phase II 59 histamine dihydrochloride 59 DermaVir 59 APEX PD 59 talabostat 59 Phase 1b trial 59 HCD# [002] 59 recurrent glioma 59 Imvamune R 59 nanoviricides 59 ASONEP 59 novel nucleoside analog 59 IAP inhibitors 59 ARIXTRA R 59 PEG PAL 59 Intravenous CP 59 alemtuzumab Campath 59 Valortim 59 LEUKINE 59 liposomal ciprofloxacin 59 cediranib 59 Trovax 59 Phase #/#a 59 Genasense ® 59 huN# DM1 59 preclinical toxicology 59 Pirfenidone 59 LEVADEX ™ 59 therapeutic monoclonal antibodies 59 Telintra 59 synthetic retinoid 59 AIMM trial 59 teriflunomide 59 SCENESSE ® 59 Ramoplanin 59 mapatumumab 59 TransVax tm 59 REG2 59 Phase 2a trial 59 RGB # 59 Neuradiab 59 Prodarsan ® 59 cilengitide 59 prepandemic 59 Tarvacin TM 59 TRO# 59 VivaGel ™ 59 bacillus Calmette Guerin BCG 59 delivers fluocinolone acetonide FA 59 ZACTIMA 59 demonstrated antitumor activity 59 successfully commercialize Iluvien 59 docetaxel Taxotere ® 59 Novolimus 59 CD# monoclonal antibody 59 LE DT 59 ORMD 59 Fibrin Pad 59 phase III isavuconazole 59 intravesical infusion therapy 59 NeuroFlo 59 DCVax 59 TransVax ™ 59 NPC 1C 59 Pertuzumab 59 including eniluracil ADH 59 MKC# MT 59 immunological diseases 59 QLT# 59 omega interferon 59 Solazed TM 59 virosome 59 Safinamide 59 Methylnaltrexone 59 NP2 59 sorafenib Nexavar 59 Viramidine 59 anticoagulant reversing agent 59 JAK2 inhibitor 59 KINRIX 59 Plicera 59 CRMD# 59 SinuNase ™ 59 Blinatumomab 59 registrational 59 Pralatrexate 59 MyVax R 59 receptor tyrosine kinase inhibitor 59 GAMMAGARD 59 Zenvia ™ 59 Phase 1a clinical 59 GVAX Pancreas Vaccine 59 sorafenib tablets 59 CDP# 59 MGd 59 KL4 surfactant 59 FDA Approvable Letter 59 trodusquemine 59 dirucotide 59 Pimavanserin 59 Glufosfamide 59 personalized immunotherapy 59 trastuzumab DM1 59 Bioral Amphotericin B 59 Metastatic Melanoma 59 IMC A# 59 Phase 2a 59 Panzem R 59 Genvec 59 nucleoside analog 59 ThermoDox ® clinical 59 ruxolitinib 59 ixabepilone 59 AAG geldanamycin analog 59 DEB# 59 drug pipeline TAFA# 59 Vicriviroc 59 Degarelix 59 OvaRex MAb 59 radiation sensitizer 59 Rhucin ® recombinant 59 Initiates Enrollment 59 lapatinib Tykerb 59 Begins Dosing 59 Phase Ia 59 RELOVAIR ™ 59 SIR Spheres 59 G#DT 59 HEPLISAV TM 59 Phase IIa trial 59 Junovan 59 proteasome inhibitor 59 Iluvien ® 59 DermaPrep 59 Topical Interferon Alpha 2b 59 EGEN 59 BIM #A# 59 Telavancin 59 compound INCB# 59 LibiGel testosterone gel 59 recombinant subunit vaccine 59 LungAlert TM 59 MVA#A 59 miconazole Lauriad R 59 ImmuKnow R 59 M Vax 59 HGS ETR1 mapatumumab 58 DCVax Brain 58 ARIKACE 58 PNP inhibitor 58 vaginally administered lidocaine 58 Viral Immunotherapy platform 58 AE# vaccine 58 Prodarsan R 58 TKB# 58 Intercell vaccine 58 Bioral ® 58 cystinosis patients 58 Phase III Clinical Trial 58 OncoGel 58 CINTREDEKIN BESUDOTOX 58 Canvaxin 58 Initiates Phase II 58 MEK inhibitors 58 pan HDAC inhibitor 58 Alfimeprase 58 topically applied SEPA 58 PI3K/Akt pathway inhibitor 58 Enobia 58 TBC M4 58 Aeroquin 58 Virosome Biologicals 58 Onrigin 58 phase IIb 58 Vacc 4x 58 Curaxin 58 Phase 1a 58 phase IIb trial 58 WX UK1 58 Hematide ™ 58 oral proteasome inhibitor 58 Clolar ® 58 Alvine Pharmaceuticals 58 delafloxacin 58 PHX# 58 StaphVAX 58 modified glutathione analog 58 DDP# 58 Tarvacin 58 PDX pralatrexate 58 LC#m# 58 Sym# 58 Trofex 58 HepaGam B 58 Cytolin ® 58 intranasal formulation 58 REMUNE R 58 triphendiol 58 NovaBay Aganocide compounds 58 pentostatin 58 MEK inhibitor 58 commercialize deforolimus 58 BZL# 58 ISF# 58 Kamada AAT 58 BiTE R 58 recurrent glioblastoma multiforme 58 EFAPROXYN 58 orally administered inhibitor 58 tezampanel 58 recombinant hepatitis B 58 initiate multicenter 58 H#N# VLP vaccine 58 BCR ABL inhibitor 58 erlotinib Tarceva ® 58 Doribax 58 Initiates Clinical 58 dalbavancin 58 SCIB1 58 Onalta ™ 58 recurrent NSCLC 58 anti CD3 monoclonal 58 Phase 1b clinical 58 oral rivaroxaban 58 solithromycin 58 Diamyd ® 58 PLK1 SNALP 58 diarrhea predominant irritable 58 cetuximab Erbitux R 58 LibiGel Phase III 58 Panzem 58 assessing T DM1 58 Zenpep 58 Retacrit 58 hypoxia activated prodrug 58 Civacir 58 HGS# 58 Ophena 58 eniluracil 58 AERAS 58 Lixivaptan 58 initiate Phase 1b 58 PXD# 58 hepatitis C HCV 58 PEARL SC 58 NeuroSTAT ® 58 GSK# [002] 58 metastatic gastric 58 depsipeptide 58 indibulin 58 cariprazine 58 Zemiva TM 58 dose escalation Phase 58 Aquinox 58 SEPET TM 58 Arno Therapeutics 58 CB2 selective receptor agonist 58 Triapine 58 superficial bladder cancer 58 Phase IIa trials 58 relapsing remitting MS RRMS 58 elacytarabine 58 Adaptive Radiation Therapy 58 Protalex Inc. 58 GED aPC 58 CoAxia 58 LibiGel ® 58 cabozantinib 58 methylnaltrexone 58 pharmacokinetic studies 58 live attenuated influenza 58 oral deforolimus 58 Arranon 58 refractory chronic lymphocytic 58 Prosaptide 58 MAA submission 58 ONCASPAR 58 multicenter Phase 58 cellular immunotherapy 58 PF # [002] 58 TKM PLK1 58 Completes Patient Enrollment 58 methylnaltrexone bromide 58 VIR# 58 administered intramuscularly 58 Modified Vaccinia Ankara MVA 58 sitaxsentan 58 midstage clinical 58 paclitaxel poliglumex 58 L BLP# 58 Thiarabine 58 Phase IIIb study 58 human C1 inhibitor 58 Peginterferon alfa 2b 58 investigational immunotherapy 58 Fludara ® 58 LymphoStat B belimumab 58 tezampanel NGX# 58 vapreotide acetate 58 orally bioavailable 58 Dasatinib 58 ThermoDox R 58 Kahalalide F 58 EVIZON TM 58 prGCD 58 IAP inhibitor 58 autologous cellular immunotherapy 58 Protexia ® 58 Deforolimus 58 EXPAREL ™ 58 XL# XL# XL# XL# 58 galiximab 58 Zybrestat 58 budesonide MMX Phase III 58 MAb therapy 58 blinded randomized placebo controlled 58 PEGylated interferon 58 SNT MC# 58 metastatic bladder 58 ADVEXIN p# therapy 58 Zemiva ™ 58 oral antiviral 58 obatoclax 58 MEK Inhibitor 58 EDEMA3 58 Lucanix R 58 oral talactoferrin 58 AeroLEF TM 58 POSIDUR TM 58 RSD# oral 58 Troxatyl 58 RiVax ™ 58 olaparib 58 Darinaparsin 58 eritoran 58 R#/MEM # 58 rALLy trial 58 trastuzumab Herceptin R 58 Dual Opioid 58 randomized discontinuation 58 cMET 58 prospective randomized multicenter 58 VNP#M 58 Cx# [002] 58 Achieves Primary Endpoint 58 SNALP technology 58 Nanobody 58 AZILECT ® 58 afamelanotide 58 BENLYSTA ® 58 mitogen activated ERK kinase 58 Phase IIa clinical 58 confirmatory Phase 3 58 AQ4N 58 trivalent influenza vaccine 58 CCR9 antagonist 58 FavId 58 velafermin belinostat 58 lintuzumab 58 PRECISE Trial 58 adecatumumab 58 next generation URAT1 58 Zerenex 58 vivo validation 58 Cerashield 58 QuadraSphere 58 XL# XL# 58 Genasense oblimersen sodium Injection 58 PA# [002] 58 phase IIIb 58 TOCOSOL Paclitaxel 58 relapsed MM 58 JAK2 Inhibitor 58 JAK inhibitors 58 generation purine nucleoside 58 Trastuzumab DM1 58 histone deacetylase HDAC inhibitor 58 Vaxfectin TM formulated 58 registrational trial 58 AMPAKINE CX# 58 brivaracetam 58 Restanza 57 thorough QT 57 Kuvan R 57 Ophena TM 57 Successfully Completes Phase 57 HGS ETR2 57 SynCon ™ DNA 57 NDA Submission 57 Aclidinium 57 TransVax 57 telaprevir VX 57 Phase 2a preventative 57 midstage clinical trials 57 CAPHOSOL R 57 Phase III Trials 57 PKC# 57 recurrent metastatic ovarian cancer 57 Exelixis XL# 57 clinicaltrials 57 Truvada tablets 57 novel immunotherapeutic 57 BRAF inhibitor 57 KRN# 57 TLR9 agonist 57 MBP# [001] 57 refractory prostate cancer 57 Lodotra TM 57 Rotarix ® 57 Dyloject TM 57 Virulizin ® 57 CUSTOM III 57 eTag assays 57 ALN TTR 57 SparVax 57 PGL# 57 TYGACIL 57 Trofex TM 57 Ocrelizumab 57 AFRS TM 57 Zosano 57 ALTROPANE R 57 aleglitazar 57 BRIM3 57 Phase Ib IIa 57 Hyphanox 57 SUTENT ® 57 R#/MEM 57 attenuated vaccine 57 Cloretazine R VNP#M 57 Simulect 57 Pivotal Trial 57 Tamibarotene 57 Crofelemer budesonide foam 57 arsenic trioxide injection 57 RSR# 57 ThGRF 57 EGS# 57 VIBEX MTX 57 Universal Flu Vaccine 57 Pivotal Clinical Trial 57 Ixempra 57 using Crucell PER.C6 57 intranasal delivery 57 SAR# [004] 57 Novavax VLP 57 investigational pan BCR 57 zanolimumab 57 Genasense R oblimersen 57 Tykerb lapatinib 57 Tanespimycin 57 ReN# 57 xTAG RVP 57 dasatinib Sprycel ® 57 octreotide implant 57 theranostic 57 ocrelizumab 57 ACTEMRA TM 57 personalized cellular immunotherapy 57 TELINTRA R 57 EnzymeRx 57 Phase lll 57 Besivance 57 Asentar 57 VIRxSYS 57 Muraglitazar 57 leading oral taxane 57 randomized Phase IIb 57 seliciclib CYC# 57 INS# [001] 57 pivotal bioequivalence 57 vemurafenib 57 VersaFilm 57 otelixizumab 57 VLP vaccine 57 Ataluren 57 dextofisopam 57 JAK2 inhibitors 57 BiondVax 57 evaluating mipomersen 57 Spiegelmer ® 57 European Sepsis Trial 57 lenalidomide Revlimid R 57 Dapagliflozin 57 acadesine 57 Phase 2b Trial 57 PCV# 57 EOquin 57 thymalfasin 57 alfa 2a 57 TASKi3 57 ENMD # 57 Daniel Junius 57 BCX# 57 monoclonal antibody MAb 57 baminercept 57 humanized monoclonal 57 HCV protease inhibitors 57 Specifid 57 dose escalation phase 57 Hiberix 57 optimal dosing regimens 57 Pentacel vaccine 57 ChronVac C 57 HCV NS5B polymerase 57 TransMID 57 drug conjugate 57 deCODE ProstateCancer TM 57 Mipomersen 57 GAP #B# 57 TASKi2 57 recurrent herpes labialis 57 IMVAMUNE ® 57 Xcytrin R 57 dose escalation clinical 57 novel peptide 57 canakinumab 57 NEUMUNE 57 thalidomide Thalomid 57 Toctino ® alitretinoin 57 PFO migraine 57 SUPPRELIN R LA 57 Azedra TM 57 Circ Pharma 57 ospemifene 57 Ixabepilone 57 Anidulafungin 57 deforolimus 57 masitinib 57 MOZOBIL 57 molecular diagnostic assay 57 ERYtech Pharma 57 Initiate Phase 57 Voreloxin 57 phase 2a 57 oral methylnaltrexone 57 lorvotuzumab mertansine 57 CVac 57 ISTODAX 57 Kevetrin TM 57 Gliadel Wafer 57 Urocidin TM 57 XL# anticancer compounds 57 Inovocox TM 57 LHRH receptor positive 57 investigational HCV polymerase 57 Zenvia Phase III 57 Denufosol 57 MT#/MEDI-# 57 siRNA therapeutic 57 Atiprimod 57 IMPACT IMmunotherapy 57 accumulate preferentially 57 Enzastaurin 57 Hedgehog pathway inhibitor 57 optimal dosing 57 VALSTAR 57 inhaled formulation 57 Hsp# Inhibitor 57 confirmatory clinical 57 rALLy 57 Aviptadil 57 subcutaneous PRO 57 Scil Proteins 57 HuLuc# 57 candidate CRLX# 57 AOP Orphan 57 IMPACT DCM 57 Therinject 57 initiated Phase Ib 57 Nanobody ® 57 NOX E# 57 trastuzumab emtansine T DM1 57 albiglutide 57 Vernakalant 57 cat dander allergy 57 Fabry Disease 57 oxymorphone ER 57 Manja Bouman CEO 57 molecular imaging radiopharmaceutical 57 Silodosin 57 IIa clinical 57 Vaxfectin R formulated 57 NanoCrystal technology 57 BrachySil ™ 57 Phase 2b clinical trials 57 Dose Ranging Study 57 AERAS-#/Crucell Ad# 57 dirucotide MBP# 57 vinca alkaloid 57 multi kinase inhibitor 57 oral ghrelin agonist 57 Maribavir 57 humanized anti 57 pharmacodynamic effects 57 novel VDA molecule 57 NEUVENGE 57 Aganocide 57 Cethrin R 57 ganaxolone 57 metastatic castration resistant 57 Aurora kinase inhibitors 57 Relenza zanamivir 57 aldehyde dehydrogenase ALDH2 deficiency 57 bardoxolone 57 eprotirome 57 CTA# Injection 57 VALOR trial 57 VitiGam TM 57 Focetria 57 Varicella chicken pox 57 investigational protease inhibitor 57 TOLAMBA